Ηλικία, φύλο και ανοσοποιητικό σύστημα τα στοιχεία που αυξάνουν τον κίνδυνο θανάτου από covid19

Cancer Immunotherapy: A Revolution That Continues to Transform Cancer Care

Over the past fifteen years, cancer immunotherapy has transformed the landscape of oncology, offering new hope and treatment possibilities to patients around the world. What began as a promising scientific concept has evolved into one of the most important pillars of modern cancer treatment.

According to the Cancer Immunotherapy Insights & Impact Report 2026 published by the Cancer Research Institute, a total of 156 immunotherapy approvals were granted by the U.S. Food and Drug Administration (FDA) between 2011 and 2025, reflecting the remarkable growth and impact of this field. Many of these therapies are based on immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells more effectively.

Unlike traditional treatments such as chemotherapy and radiation therapy, immunotherapy works by empowering the body’s own immune system to fight cancer. By enhancing natural immune responses, these therapies can help the body identify and destroy cancer cells that might otherwise evade detection. For many patients, immunotherapy has led to longer survival, improved disease control, and a better quality of life.

The year 2025 marked another milestone in the advancement of cancer immunotherapy, with thirteen new FDA approvals. Notably, patients with anal cancer gained access to their first approved immunotherapy option, highlighting the expanding reach of these innovative treatments. New methods of administration, including subcutaneous therapies, are also making treatment more convenient and accessible for patients.

Research in cancer immunotherapy continues to progress at an extraordinary pace. Scientists are developing new strategies to overcome the mechanisms that allow cancer to hide from the immune system, while exploring novel therapeutic targets, combination treatments, and personalized approaches to care. These advances aim to increase the number of patients who can benefit from immunotherapy and improve outcomes across a wider range of cancers.

While challenges remain and not all patients respond equally to treatment, immunotherapy represents one of the most significant breakthroughs in the history of cancer care. Ongoing scientific innovation continues to bring hope that more effective, personalized, and accessible treatments will become available in the years ahead.

At KAPA3, we recognize the importance of raising awareness about advances in cancer treatment and supporting informed decision-making. Knowledge empowers patients, families, caregivers, and healthcare professionals, helping them navigate the cancer journey with greater confidence and hope.

Source: https://www.cancerresearch.org/cancer-immunotherapy-report-2026

Participation in CA21152 – Implementation Network Europe for Cancer Survivorship Care

Digital Health and Cancer Survivorship: Kapa3 at the INE-CSC 2026 Conference in Coimbra

The Cancer Guidance Center – Kapa3 participated in the INE-CSC 2026 Conference, part of CA21152 – Implementation Network Europe for Cancer Survivorship Care (INE-CSC), held on 25–26 May 2026 at the Faculty of Medicine (Polo III), University of Coimbra, in Coimbra, Portugal.

The conference was held under the theme “The Next Chapter – Empowering Individuals, Families, and Society for Cancer Survivorship & Supportive Care”, highlighting the need for new approaches to cancer survivorship, supportive care and the translation of innovation into real-world impact for people living with and beyond cancer, their families and society.

Kapa3’s presence in Coimbra represents another important step in its European engagement and in its ongoing effort to connect everyday experience in supporting cancer patients in Greece with European knowledge, research, digital innovation and health policy.

A key highlight was the participation in a round table discussion on facilitators and barriers to the implementation of digital health tools in oncology. The discussion was co-organised by Aristea Kyriaki Ladas and Christos Frantzidis and brought together voices from different European countries and organisations, including representatives from Kapa3, Acreditar Portugal, Liga Portuguesa Contra o Cancro, ORCO / Madrid Regional Ministry of Health, as well as participants from Poland, Latvia and the United Kingdom.

Among the participants in the round table were Yannis Kontogiorgis and Despoina Pistiolis from Kapa3, Greece, contributing to the European dialogue on digital health, oncology navigation and the participatory development of solutions that respond to the real needs of patients and caregivers.

One of the key messages of the discussion was that digital innovation in oncology is not only a technological challenge. It is also a matter of policy, implementation, equity, trust and accessibility.

For digital tools to make a meaningful difference in cancer care and survivorship, they cannot remain isolated applications or pilot projects. They need to become part of real care pathways, be supported by appropriate policy environments, connect with interdisciplinary practice and be evaluated in terms of effectiveness, implementation readiness, accessibility, equity, sustainability and value.

The discussion also highlighted that digital tools must be designed around the real needs of patients and survivors, not only around technical possibilities. Accessibility across countries, languages, healthcare systems and levels of digital and health literacy must be built in from the beginning.

The role of patient organisations and cancer support communities was also identified as essential. These organisations can act as a bridge between technological innovation and the everyday reality of people affected by cancer. They understand the questions, barriers, fears and needs that are often not fully captured by formal care systems.

For Kapa3, this participation is directly linked to the development of Myrto, its digital health and rights navigator, designed as a tool for empowerment, guidance and support for cancer patients and their caregivers.

Myrto is not approached as a simple information tool. It is being designed as a participatory intervention built around the real needs of people with lived experience of cancer. It is connected to access to rights, social benefits, services, practical guidance and human escalation whenever needed.

The Coimbra experience strengthened the view that digital health must be human-centred, accessible, trustworthy and integrated into a broader ecosystem of care. Technology can meaningfully support cancer care only when it is designed with participation, trust, clear purpose and an equity-oriented approach.

Cancer survivorship is not only about completing treatment. It is about quality of life, mental health, social reintegration, work, family, everyday life, access to services and the feeling that no person is left alone after diagnosis or treatment.

Through its participation in European networks such as INE-CSC, Kapa3 continues to contribute to the dialogue on more equitable, participatory and person-centred cancer care. Care that uses technology without losing sight of the human being at its centre.

The future of cancer support will not depend only on better digital tools, but on better collaboration between patients, caregivers, healthcare professionals, researchers, technology partners, patient organisations and policymakers.

For Kapa3, this is at the heart of its mission: transforming knowledge into action, technology into support, and the voice of patients into services that respond to their real needs.

More information: INE-CSC – Implementation Network Europe for Cancer Survivorship Care.More information:
https://inecancersurvivorship.com

6 Awards for Kapa3 at the 4th Vouliagmeni Summer Crossing: Is There Such a Thing as a “Lonely Race”?

The Cancer Guidance Center – Kapa3 participated with great joy and emotion in the 4th Vouliagmeni Summer Swimming Crossing, an important sports and community event organised by the Vouliagmeni Nautical Club.

This year’s participation was particularly meaningful for all of us. The Kapa3 team received 6 awards, sharing a powerful message of participation, endurance, empowerment and togetherness.

But beyond the awards, what we hold most deeply is the message:

Is there really such a thing as a “lonely race”?

For us at Kapa3, the answer lies in our choice. And our choice is togetherness.

Despoina brought the idea — and much more.
Eirini stayed until the very end.

Leoni, Kalliopi, Giorgos, Christoforos, Athina, Christiana and Aria stood together as a true Winning Team.

They competed in every category, participated in every activity, informed, supported and left their own mark of empowerment, endurance and hope.

Leoni, Kalliopi, Giorgos, Christoforos, Athina, Christiana and Aria stood together as a true Winning Team.

They competed in every category, participated in every activity, informed, supported and left their own mark of empowerment, endurance and hope.

For Kapa3, the 6 awards are not only an athletic distinction. They are a symbol. They represent the power of effort, the importance of persistence and the value of community in every difficult journey.

ust as in the sea, the cancer journey requires rhythm, breath, emotional strength and people by our side. Even when a struggle feels personal, it does not have to be — and should never be — lonely.

Kapa3’s participation in the Vouliagmeni Crossing was an act of presence and awareness. It was a way to remind everyone that support for cancer patients, caregivers and families is not limited to information or access to rights and services. It is also about creating a community that stands beside people, encourages them and reminds them that they are not alone.

The sea carries a powerful symbolism. It represents the journey, uncertainty, effort, endurance, but also freedom. Every participant in the Crossing carries their own story, their own effort and their own path. For us at Kapa3, this image is deeply connected to the experience of people affected by cancer.

At Kapa3, we know that the experience of cancer is not limited to treatment. It is connected to everyday life, emotional resilience, access to information, rights, social benefits, transportation, work, family, uncertainty and the need for human presence.

This is why every community action we participate in has a dual purpose: to inform and to unite. To make visible the need for equal access to care, while also reminding everyone that support is not an abstract concept. It is presence. It is care. It is listening. It is guidance. It is the hand that helps someone keep going.

The 4th Vouliagmeni Summer Crossing was another moment of outreach, participation and empowerment for Kapa3. A moment that showed that strength is not found only at the finish line, but also in the decision to start, to try and to keep going.

We are grateful for the support, the care, the participation and the result.

We warmly thank the Vouliagmeni Nautical Club for organising the event, as well as everyone who participated, supported and stood beside us in this initiative.

We continue to choose togetherness at Kapa3.

Because even when a race is individual, it should never be lonely.

New MELODIC Scientific Publication on the Mental Health of Young Adults with Cancer

Kapa3 participates in the new scientific publication of the European MELODIC project, entitled:

“Educational Needs Regarding Mental Health of Professionals Working with Young Adults with Cancer: A European Survey.”

The publication addresses a highly important issue in contemporary cancer care: the educational needs of healthcare professionals working with young adults with cancer, particularly in relation to recognising and supporting mental health concerns.

Young adults experiencing cancer often face complex psychosocial challenges. Diagnosis, treatment, changes in daily life, impact on studies, work, relationships, body image and future planning can deeply affect their mental health and quality of life.

The European study, involving 271 healthcare professionals from 21 countries, highlighted an important gap between professionals’ willingness to support patients and the systematic use of validated assessment tools. While approximately half of the participating professionals reported feeling confident in identifying mental health issues, only a small percentage reported using validated screening tools.

This finding is particularly important. It shows that awareness and professional experience are valuable, but they are not enough on their own. Targeted education, appropriate tools, interdisciplinary collaboration and clear support pathways are needed so that the needs of young adults with cancer can be recognised early and addressed in a comprehensive way.

The message of the publication is clear: the education of healthcare professionals can make a meaningful difference in the early recognition, support and care of young adults with cancer.

At Kapa3, this approach is a core principle of our work. Before every intervention and every support action, there is education, information and empowerment of the people who stand beside patients.

Kapa3 professionals and collaborators are trained, informed and actively involved in European projects such as MELODIC, ensuring that the support provided is evidence-informed, human-centred and meaningful.

Kapa3’s active participation in such scientific initiatives strengthens its role as an organisation that connects research with practice, European knowledge with real patient needs, and education with everyday care.

We are proud of our participation in the MELODIC project and of our contribution to a European effort that highlights the importance of mental health, early recognition and targeted education in cancer care.

More information: https://lnkd.in/e9Pw4epy

2025 – Moving Forward with Vision

The Kapa3 Annual Review 2025 reflects a year of determination and vision, as Kapa3 strengthened its impact through initiatives and collaborations focused on holistic cancer care.During the first half of the year alone, we managed more than 400 individual requests, with support for the process of Disability Certification standing out as a key service—confirming that personalized, hands-on support remains at the core of our mission.

A milestone moment in 2025 was Kapa3’s participation, alongside 13 European partners, in the EU4Health programme MELODIC, which focuses on improving mental health support for young adult cancer patients (18–39 years old). Through research mapping the training needs of healthcare professionals, the project highlights the urgent need for better detection and management of psychological distress among young patients—many of whom still lack access to adequate psychosocial care.

MELODIC promotes innovative wellbeing interventions, such as physical activity in green and blue spaces combined with psychosocial support, emphasizing the healing power of nature and community in mental health recovery. As an active partner, Kapa3 works to ensure that these actions reach patients directly, fostering community engagement and equitable access to quality care.

At the same time, our participation in the second cycle of the SmartHEALTH programme, supported by CERTH, strengthened the digital integration of healthcare services and empowered patients through smart technologies, improving efficiency, accessibility, and transparency.

Our collaboration with FairLife within the BREATH programme for lung cancer patients highlighted the importance of holistic and interdisciplinary care. In parallel, our presence at conferences and scientific events—such as COST Action INECSC CA21125 and the 7th conference “Caregivers and Depression”—consistently brought attention to the needs of caregivers and the empowerment of patients.

At both national and international levels, Kapa3 presented its work at the Lazord International Conference, the Pan-Macedonian Scientific Nursing Conference, and the ESMO World Congress in Berlin. We also participated in major events such as the Patients Summit, Morning Health Talks by EIT Health, and the 18th Panhellenic Conference on Nutrition & Dietetics.

A particularly important moment was our action in the Municipality of Megara, where a new Cancer Patient Guidance and Counselling Station was established, offering direct and personalized support to patients and their families.

Prevention and awareness remain fundamental pillars of our work. Breast self-examination initiatives, participation in the Action4Obesity network, presence at the Thessaloniki Disability Festival, and the launch of new nutrition-related sections on our website all contribute to improving the quality of life of patients and caregivers—combining scientific guidance with lived experience.

Awards 2025

In 2025, Kapa3 received significant recognition for the digital platform Cancer Care Connect, winning a Gold Award at the Diversity, Equity & Inclusion Awards, as well as the Gold Award for “NGO of the Year – Health and Social Care” at the Hellenic Responsible Business Awards 2025.
In addition, our collaboration with the University of Peloponnese received a Silver Award at the Healthcare Business Awards 2025 for the programme “Community co-design and implementation of holistic educational practices for nutrition and mental health.”

Every initiative, every partnership, and every participation brings us closer to our vision: holistic, human-centred care where the voices of patients and caregivers truly matter.

To explore our full journey from the foundation of Kapa3 through the end of 2025, you can view our comprehensive activity report here.

The Kapa3 Annual Review 2025 reaffirms our commitment to holistic, human-centred care, where the voices of patients and caregivers truly matter.

As we step into the new year, we move forward with enthusiasm, commitment, and optimism—to continue supporting patients and caregivers, investing in innovation and education, and strengthening care and participation across all our actions.

We wish everyone a year filled with health, strength, and inspiration.

The Kapa3 Team